STRS Ohio’s Trillium Therapeutics Inc. TRIL Stock Holding History

STRS Ohio’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-22,700	Closed	-$398K	–	2351
2021 Q3	$398K	Hold	22,700	–	–	﹤0.01%	1583
2021 Q2	$220K	Buy	+22,700	New	+$214K	﹤0.01%	1795

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

STRS Ohio's TRIL Position: Q4 2021 in Review

STRS Ohio sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 22,700 shares — an estimated $398K sold.

STRS Ohio first reported a position in TRIL in Q2 2021 and held it in 2 quarters. The position peaked at $398K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

STRS Ohio reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
STRS Ohio sold 22,700 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $398K.
STRS Ohio first reported a position in Trillium Therapeutics Inc. in Q2 2021 and held it in 2 quarters.
STRS Ohio's Trillium Therapeutics Inc. position peaked at $398K in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on STRS Ohio's 13F filing for Q4 2021, filed 24 Jan 2022.